Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:CYRX
NasdaqCM:CYRXLife Sciences

A Look at Cryoport’s (CYRX) Valuation Following New Smart Monitoring Solutions Launch

Cryoport (CYRX) just introduced new integrated condition monitoring solutions for its MVE Biological Solutions dewars, powered by its subsidiary Tec4Med. These upgrades aim to provide more reliable monitoring and compliance for cryogenic storage in the life sciences sector. See our latest analysis for Cryoport. Cryoport’s launch of intelligent monitoring solutions seems to have caught the market’s attention, with the latest 90-day share price return surging 40.75% and year-to-date performance...
ENXTLS:ALTR
ENXTLS:ALTRForestry

Will Valmet's €75 Million Evaporation Line Supply Shift Altri SGPS' (ENXTLS:ALTR) Textile Ambitions?

Valmet announced in October 2025 that it will supply a new 7-effect evaporation line to the Altri Biotek mill in Portugal as part of a €75 million project to convert the site for dissolving pulp production targeting the textile industry, with startup planned in the third quarter of 2027. This investment is expected to improve the mill's energy and water efficiency, supporting Altri’s goal of expanding into renewable textile fiber markets with higher value-added products. We’ll explore how...
BME:VIS
BME:VISFood

Viscofan (BME:VIS) Is Down 8.4% After Danville Factory Faces Environmental Scrutiny – Has the Bull Case Changed?

Regulatory records and employee accounts reveal that Viscofan's Danville, Illinois factory has faced repeated environmental law violations and is under scrutiny for hazardous waste disposal and toxic emissions, with the Illinois EPA considering legal action. This situation has sparked significant reputational risk for Viscofan, challenging its stated commitments to environmental compliance and worker safety amid ongoing expansion efforts. We'll examine how persistent regulatory scrutiny over...